Related Experiment Video
Updated: Oct 23, 2025

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Cardiac macrophage subsets differentially regulate lymphatic network remodeling during pressure overload
Mathilde Bizou1,2, Romain Itier1,3,2, Mina Majdoubi1,2
1I2MC, Toulouse University, Inserm, Université Paul Sabatier, Toulouse, France.
Insights
Cardiac macrophages play a key role in heart failure progression. Specific macrophage subsets regulate lymphatic vessel remodeling, impacting heart function during pathological hypertrophy.
Area of Science:
- Cardiovascular Biology
- Immunology
- Lymphatic System Research
Background:
- The cardiac lymphatic network regulates interstitial fluid and immune cell movement.
- Heart hypertrophy and failure lead to cardiac lymphatic remodeling and reduced efficiency.
Purpose of the Study:
- To investigate the role of cardiac macrophage subpopulations in regulating cardiac lymphatic remodeling during pressure overload.
- To identify specific macrophage markers and functions involved in pathological cardiac hypertrophy.
Main Methods:
- Induction of heart hypertrophy and failure via transverse aortic constriction in mice.
- Analysis of cardiac lymphatic vessels and macrophage populations (LYVE-1 positive/negative).
- Assessment of lymphangiogenesis and gene expression (MMP12, CCR2).
- Treatment with a CCR2 antagonist to evaluate its effect on macrophage subsets and lymphatic remodeling.
Main Results:
- Cardiac lymphatic remodeling and reduced efficiency were observed during heart failure.
- A subset of LYVE-1 positive cardiac macrophages promoted lymphangiogenesis.
- LYVE-1 negative macrophages expressed MMP12, contributing to lymphatic remodeling.
- CCR2 antagonist treatment preserved the lymphatic network by altering macrophage proportions.
Conclusions:
- Distinct cardiac macrophage subpopulations have differential roles in regulating cardiac lymphatic function during pathological hypertrophy.
- Macrophage-mediated lymphatic remodeling is a key mechanism in heart failure progression.
- Targeting CCR2-mediated pathways may offer therapeutic strategies for heart failure.
Abstract:
The lymphatic network of mammalian heart is an important regulator of interstitial fluid compartment and immune cell trafficking. We observed a remodeling of the cardiac lymphatic vessels and a reduced lymphatic efficiency during heart hypertrophy and failure induced by transverse aortic constriction. The lymphatic endothelial cell number of the failing hearts was positively correlated with cardiac function and with a subset of cardiac macrophages. This macrophage population distinguished by LYVE-1 (Lymphatic vessel endothelial hyaluronic acid receptor-1) and by resident macrophage gene expression signature, appeared not replenished by CCR2 mediated monocyte infiltration during pressure overload. Isolation of macrophage subpopulations showed that the LYVE-1 positive subset sustained in vitro and in vivo lymphangiogenesis through the expression of pro-lymphangiogenic factors. In contrast, the LYVE-1 negative macrophage subset strongly expressed MMP12 and decreased the endothelial LYVE-1 receptors in lymphatic endothelial cells, a feature of cardiac lymphatic remodeling in failing hearts. The treatment of mice with a CCR2 antagonist during pressure overload modified the proportion of macrophage subsets within the pathological heart and preserved lymphatic network from remodeling. This study reports unknown and differential functions of macrophage subpopulations in the regulation of cardiac lymphatic during pathological hypertrophy and may constitute a key mechanism underlying the progression of heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Inflammation

